AZN vs BRNS · P/E 28, $288.38B cap vs $38.2M cap
AstraZeneca PLC (AZN) versus Barinthus Biotherapeutics plc (BRNS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. BRNS currently screens at market cap $38.2M.
Not investment advice. Open the AZN and BRNS stock pages for the full models.
Not investment advice.